Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis. Issue 3 (March 2021)
- Record Type:
- Journal Article
- Title:
- Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis. Issue 3 (March 2021)
- Main Title:
- Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis
- Authors:
- Hoofien, Assaf
Rea, Francesca
Espinheira, Maria do Céu
Amil Dias, Jorge
Romano, Claudio
Oliva, Salvatore
Auth, Marcus Karl-Heinz
Zangen, Tsili
Kalach, Nicolas
Domínguez-Ortega, Gloria
De Angelis, Paola
Zevit, Noam - Abstract:
- Abstract: Background: The role of systemic steroids in the treatment of esophageal strictures in children with Eosinophilic Esophagitis (EoE) is poorly defined. Aims: To describe a cohort of children with EoE-associated esophageal strictures responding to systemic steroids. Methods: Retrospective review of medical records of children with EoE and moderate (<9 mm) to severe (<6 mm) strictures, who responded clinically and endoscopically to systemic steroids. Results: Twenty children (median age 10.6 ± 4.2 years; 17 males) from nine centers in six countries were included in the analysis; 16 had moderate and four, severe strictures; 18 had dysphagia or bolus impaction; median diagnostic delay was 8 months (IQR 3.5–35). Eighteen patients received oral systemic steroids (mean dose 1.4 mg/kg/day) for a median of 4 weeks, while two initially received IV steroids. All patients showed clinical improvement and 15/20 became asymptomatic. Stricture resolution at endoscopy was found in 19/20, while histological resolution of EoE (<15 eos/hpf) in 13/20. Only minor side effects were reported: hyperphagia (10/20); weight gain (5/20); hyperactivity (2/20) and acne (1/20). Esophageal dilation was required in 3/20 patients during a median follow-up of 48.5 months (IQR 26.7–73.2). Conclusion: Children with EoE and esophageal strictures, may benefit from the use of a short course of systemic steroids, avoiding mechanical dilation.
- Is Part Of:
- Digestive and liver disease. Volume 53:Issue 3(2021)
- Journal:
- Digestive and liver disease
- Issue:
- Volume 53:Issue 3(2021)
- Issue Display:
- Volume 53, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 53
- Issue:
- 3
- Issue Sort Value:
- 2021-0053-0003-0000
- Page Start:
- 324
- Page End:
- 328
- Publication Date:
- 2021-03
- Subjects:
- Children -- Dilation -- Eosinophilic oesophagitis -- Prednisone -- Treatment
EoE Eosinophilic Esophagitis -- GERD Gastroesophageal Reflux Disease -- PPI Proton Pump Inhibitor
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.dld.2020.11.025 ↗
- Languages:
- English
- ISSNs:
- 1590-8658
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15806.xml